Key result
In human adrenal tissues, angiotensin II-induced aldosterone secretion was suppressed 50% by an AT1 antagonist, while an AT2 agonist increased secretion by 55% over control.
Population
Human adrenal tissues: normal adrenocortical tissues, aldosterone-producing adrenocortical adenoma…
Comparison
In vitro incubation with angiotensin II with or… vs Control (no antagonist/agonist).
Design
Preclinical
Authors
Loading...
AT2 receptors may contribute to aldosterone secretion; hypothesis-generating for dual AT1/AT2 targeting, pending clinical studies.
Both AT1 and AT2 receptors are expressed in human adrenal tissues and may be involved in regulating aldosterone secretion and tumorigenesis.
Tanabe et al. (1998) studied Normal and tumorous human adrenal tissues (n=24). Angiotensin II with or without AT1 antagonist (CV-11974) or AT2 agonist (CGP-42112) vs. Control was evaluated on Aldosterone and cortisol secretion. In human adrenal tissues, angiotensin II-induced aldosterone secretion was suppressed 50% by an AT1 antagonist, while an AT2 agonist increased secretion by 55% over control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: